Responding to the Patent CliffByNathan JessopJuly 1st 2013Pharmaceutical Technology EuropeAs the dreaded patent cliff continues to haunt the pharmaceutical industry, some companies are resorting to desperate measures to delay generic drug entry into the market.
Pharmaceutical Technology Europe, July 2013 Issue (PDF)July 1st 2013Pharmaceutical Technology EuropePharmaceutical Technology Europe, July 2013 Issue (PDF)